D1ASP0RA (Madison, WI) is a foundry formed in 2016 to launch disruptive healthcare ventures. Thus far we have launched five companies. Areas of primary interest include precision medicine, regenerative medicine, and phenotypic discovery. Precision medicine improves healthcare decisions by tailoring treatments to each patient. Regenerative medicine targets unmet needs by repairing tissues damaged from disease. Phenotypic discovery identifies more effective drugs. These three areas are key to future healthcare innovation. They operate on common platform technologies including clinical genomics and manufactured cells.
2019.02.04 - Ligand Announces Investment in Dianomi Therapeutics